BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 31947665)

  • 21. Pathogenic mechanism of mouse brain damage caused by oral infection with Shiga toxin-producing Escherichia coli O157:H7.
    Kita E; Yunou Y; Kurioka T; Harada H; Yoshikawa S; Mikasa K; Higashi N
    Infect Immun; 2000 Mar; 68(3):1207-14. PubMed ID: 10678928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Toxic Environment: a Growing Understanding of How Microbial Communities Affect Escherichia coli O157:H7 Shiga Toxin Expression.
    Nawrocki EM; Mosso HM; Dudley EG
    Appl Environ Microbiol; 2020 Nov; 86(24):. PubMed ID: 32358004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Towards an attenuated enterohemorrhagic Escherichia coli O157:H7 vaccine characterized by a deleted ler gene and containing apathogenic Shiga toxins.
    Liu J; Sun Y; Feng S; Zhu L; Guo X; Qi C
    Vaccine; 2009 Oct; 27(43):5929-35. PubMed ID: 19682616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preservation of protective capacity of hyperimmune anti-Stx2 bovine colostrum against enterohemorrhagic Escherichia coli O157:H7 pathogenicity after pasteurization and spray-drying processes.
    Garimano N; Diaz Vergara LI; Kim AD; Badin EE; Sodero S; Bernal AM; Gonzalez DD; Amaral MM; Lespinard AR; Porporatto C; Montenegro MA; Palermo MS; Larzabal M; Cataldi AA; Ibarra C; Sacerdoti F
    J Dairy Sci; 2021 May; 104(5):5229-5238. PubMed ID: 33685676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of RecA on in vivo virulence and Shiga toxin 2 production in Escherichia coli pathogens.
    Fuchs S; Mühldorfer I; Donohue-Rolfe A; Kerényi M; Emödy L; Alexiev R; Nenkov P; Hacker J
    Microb Pathog; 1999 Jul; 27(1):13-23. PubMed ID: 10371706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abundance in sewage of bacteriophages infecting Escherichia coli O157:H7.
    Muniesa M; Jofre J
    Methods Mol Biol; 2004; 268():79-88. PubMed ID: 15156020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Shiga toxins decrease enterohaemorrhagic Escherichia coli survival within Acanthamoeba castellanii.
    Chekabab SM; Daigle F; Charette SJ; Dozois CM; Harel J
    FEMS Microbiol Lett; 2013 Jul; 344(1):86-93. PubMed ID: 23581502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exocytotic secretion of toxins from macrophages infected with Escherichia coli O157.
    Shimada O; Ishikawa H; Tosaka-Shimada H; Atsumi S
    Cell Struct Funct; 1999 Oct; 24(5):247-53. PubMed ID: 15216879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salt at concentrations relevant to meat processing enhances Shiga toxin 2 production in Escherichia coli O157:H7.
    Harris SM; Yue WF; Olsen SA; Hu J; Means WJ; McCormick RJ; Du M; Zhu MJ
    Int J Food Microbiol; 2012 Oct; 159(3):186-92. PubMed ID: 23107496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of Escherichia coli Isolates from humans, food, and farm and companion animals for presence of Shiga toxin-producing E. coli virulence markers.
    Murinda SE; Nguyen LT; Landers TL; Draughon FA; Mathew AG; Hogan JS; Smith KL; Hancock DD; Oliver SP
    Foodborne Pathog Dis; 2004; 1(3):178-84. PubMed ID: 15992278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of the transcription of the Escherichia coli O157:H7 genes coding for shiga-like toxins and intimin, and its potential use in the treatment of human infection with the bacterium.
    Matar GM; Rahal E
    Ann Trop Med Parasitol; 2003 Apr; 97(3):281-7. PubMed ID: 12803859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The serine 31 residue of the B subunit of Shiga toxin 2 is essential for secretion in enterohemorrhagic Escherichia coli.
    Shimizu T; Kawakami S; Sato T; Sasaki T; Higashide M; Hamabata T; Ohta T; Noda M
    Infect Immun; 2007 May; 75(5):2189-200. PubMed ID: 17325057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunization of pregnant cows with Shiga toxin-2 induces high levels of specific colostral antibodies and lactoferrin able to neutralize E. coli O157:H7 pathogenicity.
    Albanese A; Sacerdoti F; Seyahian EA; Amaral MM; Fiorentino G; Fernandez Brando R; Vilte DA; Mercado EC; Palermo MS; Cataldi A; Zotta E; Ibarra C
    Vaccine; 2018 Mar; 36(13):1728-1735. PubMed ID: 29483033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pro-inflammatory capacity of Escherichia coli O104:H4 outbreak strain during colonization of intestinal epithelial cells from human and cattle.
    Stalb S; Barth SA; Sobotta K; Liebler-Tenorio E; Geue L; Menge C
    Int J Med Microbiol; 2018 Oct; 308(7):899-911. PubMed ID: 29937390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiplex real-time PCR assay for detection of Escherichia coli O157:H7 and screening for non-O157 Shiga toxin-producing E. coli.
    Li B; Liu H; Wang W
    BMC Microbiol; 2017 Nov; 17(1):215. PubMed ID: 29121863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of a recombinant Intimin, EspB and Shiga toxin 2B vaccine in calves experimentally challenged with Escherichia coli O157:H7.
    Martorelli L; Garimano N; Fiorentino GA; Vilte DA; Garbaccio SG; Barth SA; Menge C; Ibarra C; Palermo MS; Cataldi A
    Vaccine; 2018 Jun; 36(27):3949-3959. PubMed ID: 29807709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [New knowledge of the molecular biology of enterohemorrhagic Escherichia coli (EHEC) O157].
    Karch H; Köhler B
    Gesundheitswesen; 1999 Oct; 61 Spec No 1():S46-51. PubMed ID: 10593045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enterohemorrhagic Escherichia coli suppresses inflammatory response to cytokines and its own toxin.
    Bellmeyer A; Cotton C; Kanteti R; Koutsouris A; Viswanathan VK; Hecht G
    Am J Physiol Gastrointest Liver Physiol; 2009 Sep; 297(3):G576-81. PubMed ID: 19556613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bovine immune response to shiga-toxigenic Escherichia coli O157:H7.
    Hoffman MA; Menge C; Casey TA; Laegreid W; Bosworth BT; Dean-Nystrom EA
    Clin Vaccine Immunol; 2006 Dec; 13(12):1322-7. PubMed ID: 17050743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccination of pregnant cows with EspA, EspB, γ-intimin, and Shiga toxin 2 proteins from Escherichia coli O157:H7 induces high levels of specific colostral antibodies that are transferred to newborn calves.
    Rabinovitz BC; Gerhardt E; Tironi Farinati C; Abdala A; Galarza R; Vilte DA; Ibarra C; Cataldi A; Mercado EC
    J Dairy Sci; 2012 Jun; 95(6):3318-26. PubMed ID: 22612965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.